353281-15-9 Usage
General Description
2-Chloro-3-nitro-4-pyridinecarboxylic acid is a chemical compound that falls under the category of organic compounds known as pyridinecarboxylic acids. This category comprises compounds containing a pyridine ring bearing a carboxylic acid group. This chemical compound is less dense than water and is soluble in water. It appears as a beige to light yellow solid powder and is likely to be used in the manufacturing or processing of various industrial chemicals. As with many chemical substances, it's essential to handle this compound with proper safety measures due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 353281-15-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,3,2,8 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 353281-15:
(8*3)+(7*5)+(6*3)+(5*2)+(4*8)+(3*1)+(2*1)+(1*5)=129
129 % 10 = 9
So 353281-15-9 is a valid CAS Registry Number.
InChI:InChI=1S/C6H3ClN2O4/c7-5-4(9(12)13)3(6(10)11)1-2-8-5/h1-2H,(H,10,11)
353281-15-9Relevant articles and documents
1-CYANO-PYRROLIDINE DERIVATIVES AS INHIBITORS OF USP30.
-
Page/Page column 80, (2018/02/03)
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylatingenzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C- terminal hydrolase 30 or Ubiquitin Specific Peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of conditions involving mitochondrial dysfunction and cancer. Compounds of the invention include compounds having the formula (I) (I) or a pharmaceutically acceptable salt thereof, wherein R1, R 2, R 3, m, L and X are as defined herein.
NITROGENATED HETEROCYCLIC COMPOUND
-
Paragraph 1032; 1106, (2015/03/28)
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
